PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.07%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
822.03%
Gross profit growth above 1.5x ACB.TO's 130.94%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-112.41%
Negative EBIT growth while ACB.TO is at 38.64%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-112.41%
Negative operating income growth while ACB.TO is at 11.72%. Joel Greenblatt would press for urgent turnaround measures.
85.63%
Net income growth above 1.5x ACB.TO's 38.90%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
86.67%
EPS growth above 1.5x ACB.TO's 47.30%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
87.78%
Diluted EPS growth above 1.5x ACB.TO's 47.30%. David Dodd would see if there's a robust moat protecting these shareholder gains.
11.12%
Share count expansion well above ACB.TO's 15.99%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
13.10%
Diluted share count expanding well above ACB.TO's 15.99%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-125.44%
Negative OCF growth while ACB.TO is at 31.63%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-88.64%
Negative FCF growth while ACB.TO is at 21.18%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
549.91%
Positive 5Y CAGR while ACB.TO is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-39.53%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-3850.87%
Negative 10Y OCF/share CAGR while ACB.TO stands at 18.16%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-216.02%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
25.36%
Positive 3Y OCF/share CAGR while ACB.TO is negative. John Neff might see a big short-term edge in operational efficiency.
-2957.33%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-213.57%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-299.18%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
7956.19%
10Y equity/share CAGR above 1.5x ACB.TO's 227.58%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
304.44%
Positive 5Y equity/share CAGR while ACB.TO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
30.41%
Positive short-term equity growth while ACB.TO is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.22%
AR growth is negative/stable vs. ACB.TO's 22.30%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-0.36%
Inventory is declining while ACB.TO stands at 7.72%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.62%
Positive asset growth while ACB.TO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-7.54%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
5.45%
We have some new debt while ACB.TO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
207.41%
We increase R&D while ACB.TO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-7.22%
We cut SG&A while ACB.TO invests at 16.67%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.